UnitedHealth Group (NYSE:UNH | UNH Price Prediction) just earned a strong endorsement from four Wall Street firms following a better-than-expected
Argus upgraded its UnitedHealth Group (NYSE: UNH) stock from “Hold” to “Buy” on Wednesday, April 22, with a price target of $400, implying 15% upside from the last close of $346.
Caliber Wealth Management LLC KS boosted its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 16.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,368 shares of the healthcare conglomerate's stock after acquiring an additional
UnitedHealth Group is processing 500 million transactions this year through Optum Real, an artificial intelligence-first claims and reimbursement platform. By year end, that number is expected to hit 2.5 billion.
Waning peace-talk optimism rattled major U.S. benchmarks as UnitedHealth Group outperformed on strong earnings today, April 21, 2026.
Raul Shah talks about UnitedHealthcare (UNH) earnings. He says the healthcare giant managed some of the higher costs they faced, but it's still an ongoing risk as they move away from growth.
UnitedHealth Group (NYSE:UNH) shares jumped more than 8% on Tuesday after the health insurance giant delivered a strong first-quarter earnings beat and raised its full-year profit outlook — signaling that a prolonged period of elevated medical costs may finally be turning the corner.
UnitedHealth Group Incorporated delivered a significant Q1 double-line beat, confirming an earnings inflection and supporting renewed bullishness. Q1 revenues grew 2% year-over-year to $111.7 billion, with strong sequential improvement in earnings from operations and EPS far exceeding expectations. The medical care cost ratio improved sharply to 83.9%, reversing prior upward trends and supporting the outlook for margin expansion.
UnitedHealth Group (NYSE:UNH) stock is up 9% today, rising from $323.48 to $351.40, after the company delivered a Q1 2026 earnings report that beat expectations and raised its full-year outlook.
UNH tops Q1 EPS on strong commercial fee-based membership and Optum Rx despite Optum Health weakness and declining risk-based membership.
UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, adding uncertainty over whether health insurers would sign up for it.
UnitedHealth NYSE: UNH has hurdles to clear, but the bottom is in and a reversal is underway. Headwinds are easing, allowing the company to focus on what it does best: generating healthy cash flow from its insurance and industry-related services and paying its shareholders.